Wilmington, DE, United States of America

Diane A Trainor


Average Co-Inventor Count = 3.1

ph-index = 11

Forward Citations = 322(Granted Patents)


Location History:

  • Glen Mills, PA (US) (1986 - 1999)
  • Wilmington, DE (US) (1993 - 1999)

Company Filing History:


Years Active: 1986-1999

Loading Chart...
23 patents (USPTO):Explore Patents

Title: Diane A. Trainor: Pioneering Innovations in Pharmaceutical Developments

Introduction

Diane A. Trainor, based in Wilmington, DE, is an esteemed inventor in the field of pharmaceutical science. With a remarkable record of 23 patents to her name, she has made significant contributions toward developing innovative therapeutic compounds that address critical health issues.

Latest Patents

One of Diane's latest patents focuses on peptide derivatives that function as inhibitors of human leukocyte elastase. This invention revolves around pharmaceutically useful trifluoromethyl ketone substituted di-, tri-, and tetra-peptide derivatives. These compounds not only highlight the importance of peptide chemistry but also promise advancements in treating conditions related to inflammation.

Additionally, her work encompasses compounds designed for the treatment of urinary incontinence, demonstrating her commitment to developing effective therapies. The pharmaceutical compositions and processes detailed in her patents showcase her innovative approach and deep understanding of peptide chemistry and pharmaceutical applications.

Career Highlights

Throughout her career, Diane has been associated with notable companies, including ICI Americas Inc. and Imperial Chemical Industries Limited. Her work in these organizations has allowed her to refine her skills and contribute to groundbreaking research. The combination of her academic background and industry experience enables her to effectively bridge the gap between theoretical science and clinical application.

Collaborations

Diane has collaborated with other distinguished professionals, including Cyrus J. Ohnmacht and Mark M. Stein. These partnerships highlight her ability to work alongside some of the best minds in the field, contributing to the advancement of pharmaceutical innovations through teamwork and shared expertise.

Conclusion

Diane A. Trainor exemplifies the essence of innovation in pharmaceuticals. With a strong portfolio of patents and collaborative efforts, she continues to pave the way for future advancements in medical treatments. Her work not only enhances our understanding of peptide derivatives but also opens new avenues for addressing pressing health concerns.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…